{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Plattsburgh",
      "state": "NY",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "89059",
      "recalling_firm": "SterRx, LLC",
      "address_1": "141 Idaho Ave",
      "address_2": "",
      "postal_code": "12903-3987",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "U.S.A. Nationwide",
      "recall_number": "D-0322-2022",
      "product_description": "NOREPINEPHRINE, 16 mg per 250 mL, (64 mcg per mL) in 0.9% Sodium Chloride Injection,   SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-926-01.",
      "product_quantity": "36,576 bags",
      "reason_for_recall": "Lack of Assurance of Sterility",
      "recall_initiation_date": "20211112",
      "center_classification_date": "20211229",
      "termination_date": "20231206",
      "report_date": "20220105",
      "code_info": "S21082/BQV 13-Nov-21  S21102/BRM 28-Nov-21  S21135/BST 14-Dec-21  S21166/BTX 7-Jan-22  S21178/BUJ 28-Jan-22  S21226/BVZ 5-Feb-22  S21237/BWI 7-Feb-22  S21242/BWM 13-Feb-22  S21280/BXX 11-Mar-22  S21302/BYS 21-Mar-22  S21345/CAE 23-Apr-22  S21424/CDG 28-May-22",
      "more_code_info": ""
    }
  ]
}